Table 3 Comparison of patients with and without atherosclerotic plaques

Age (years - mean ± SD)

54.2 ± 9.8

59.9 ± 9.7

0.014^a

Disease length (years - mean ± SD)

16.3 ± 9.7

21.9 ± 8

0.011^a

Postmenopausal (n (%)): No

Yes

21 (91.3)

50 (70.4)

2 (8.7)

21 (29.6)

0.043^b

LDL within goal (Ref. 65) (n (%)) No

Yes

56 (70)

22 (100)

24 (30)

0 (0)

0.003^b

Global CVR score (median (IQR))

6.3 (2.9–11.6)

8.7 (6.2–11.8)

0.048^c

IMT (mm - median (IQR))

0.6 (0.6–0.8)

0.8 (0.7–0.9)

0.001^c

IL-33 (n (%))^d: positive

negative

52 (76.5)

26 (76.5)

16 (23.5)

8 (23.5)

1^b

IL-33 (pg/mL - median (IQR))^e

33.1 (0–78.7)

12.1 (0–85.8)

0.856^c

IL-33 (pg/mL - median (IQR))^f

69.1 (33.1–124.3)

70.6 (12.1–90.1)

0.745^c

sST2 (pg/mL - median (IQR))^g

461.7 (316.6–651)

485.9 (372.9–649)

0.675^c

IL-33/sST2 (median (IQR))^h

0.1 (0–0.3)

0.1 (0–0.3)

0.965^c